Betrixaban, known by its CAS number 330942-05-7, represents a significant advancement in the field of anticoagulation. As a selective oral Factor Xa inhibitor, its pharmacological action is critical for preventing thrombotic events, particularly venous thromboembolism (VTE) in hospitalized patients. For medical professionals and researchers in the pharmaceutical sector, understanding the specifics of this compound is essential for its effective application and sourcing.

The chemical profile of Betrixaban, including its formula C23H22ClN5O3 and molecular weight of 451.91, dictates its pharmacokinetic properties and therapeutic efficacy. It is commonly supplied as a high-purity white powder, ideal for formulation into oral dosage forms. The mechanism of action involves directly inhibiting Factor Xa, a key enzyme in the coagulation cascade, thereby reducing thrombin generation and preventing clot formation. This targeted approach offers advantages in predictability and safety compared to older anticoagulants.

For medical practitioners and researchers involved in drug development, sourcing Betrixaban requires attention to purity and consistency. Manufacturers like NINGBO INNO PHARMCHEM in China provide this critical pharmaceutical intermediate, ensuring that the material used meets stringent quality standards. When you need to buy Betrixaban, selecting a supplier that offers comprehensive technical data and reliable delivery is paramount to the success of your research or treatment protocols.

The primary application of Betrixaban lies in the prophylaxis of VTE, a serious condition often encountered in patients with limited mobility or other risk factors. Its oral administration and selective inhibition of Factor Xa make it a convenient and effective option. Medical professionals often rely on the availability of such compounds from reputable suppliers to support patient care and advance clinical research. Understanding the price and supply landscape from global manufacturers is a key part of this process.

In summary, Betrixaban is a crucial pharmaceutical compound with a well-defined role in preventing blood clots. Its sophisticated mechanism as a Factor Xa inhibitor makes it a valuable tool in modern medicine. For those involved in its procurement or application, partnering with reliable suppliers and understanding its chemical and pharmacological properties ensures optimal outcomes in both research and patient treatment.